ライブラリ登録: Guest
Critical Reviews™ in Oncogenesis

年間 4 号発行

ISSN 印刷: 0893-9675

ISSN オンライン: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Association between Human Papillomavirus and Epstein-Barr Virus Infections and Cancer of the Uterine Cervix

巻 24, 発行 4, 2019, pp. 379-383
DOI: 10.1615/CritRevOncog.2019031545
Get accessGet access

要約

Cervical cancer screening was revolutionized in the early 1980s with the discovery of human papillomaviruses (HPVs) as the single causative agent of the disease. Viral infections contribute to ~12% of cancers worldwide, and two DNA viruses, Epstein-Barr virus and HPV, are associated with 38% of all virus-associated cancers. Most viral-associated cancers develop after a long latency period (15−40 yr).

参考
  1. Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses. 2018;10:729-64.

  2. Ministerio da Saude (Brasil). Instituto Nacional do Cancer. Sistema de Informajao do Cancer do Colo do Utero e Mama. Brasil: Instituto Nacional do Cancer [accessed 2019 May 30]. Available from: https://www.inca.gov.br/tipos-de-cancer/cancer-do-colo-do-utero.

  3. Shi Y, Peng SL, Yang LF, Chen X, Tao YG, Cao Y. Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chinese J Cancer. 2016:35-16.

  4. zur Hausen H. Papillomaviruses in the causation of human cancers. A brief historical account. Virology. 2009;384:260-5.

  5. Epstein M, Achong B, Barr Y. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;283:702-3.

  6. Jha HC, Pei Y, Robertson ES. Epstein-Barr virus: diseases linked to infection and transformation. Front Microbiol. 2016;7:1602-5.

  7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini, M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127:2375-90.

  8. Amon W, Farrell PJ. Reactivation of Epstein-Barr virus from latency. Rev Med Virol. 2005;15:149-56.

  9. Young LS. The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol. 2000;53:238-47.

  10. Odumade OA, Hogquist KA, Balfour HH. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24:193-209.

  11. See HS, Yap YY, Yip WK, Seow HF. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol. 2008;6:18-27.

  12. Tsai MH, Raykova A, Klinke O, Bernhardt K, Gartner K, Leung CS, Geletneky K, Sertel S, Munz C, Feederle R, Delecluse HJ. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep. 2013;5:458-70.

  13. Sixbey JW, Lemon SM, Pagano JS. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet London. 1986;2:1122-4.

  14. de Lima MAP, Neto PJN, Lima LPM, Gonial ves JJ, Jag T, Teodoro IPP, Facundo HT, da Silva CGL, Lima MVA. Association between Epstein-Barr virus (EBV) and cervical carcinoma: a meta-analysis. Gyn Oncol. 2018;148:317-28.

  15. Muhr LSA, Eklund C, Dillner J. Towards quality and order in human papillomavirus research. Virology. 2018;519:74-6.

  16. Khenchouche A, Sadouki N, Boudriche A, Houali K, Graba A, Ooka T, Bouguermouh A. Human papillomavirus and Epstein-Barr virus co-infection in cervical carcinoma in Algerian women. Virol J. 2013;10:340.

  17. Naher H, Gissmann L, Freese UK, Petzoldt D, Helfrich S. Subclinical Epstein-Barr virus infection of both the male and female genital tract: indication for sexual transmission. J Invest Dermatol. 1992;98:791-3.

  18. Silver MI, Paul P, Sowjanya P, Ramakrishna G, Vedantham H, Kalpana B, Shah KV, Gravitt PE. Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. J Clin Microbiol. 2011;49:2435-9.

  19. Al Moustafa AE, Al-Antary N, Aboulkassim T, Akil N, Batist G, Yasmeen A. Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer. Hum Vaccine Immunother. 2016;12:9.

  20. Boger C, Kruger S, Behrens HM, Bock S, Haag J, Kalthoff H, Rocken C. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Ann Oncol. 2017;28(5):1005-14.

  21. Mozaffari HR, Ramezani M, Janbakhsh A, Sadeghi M. Malignant salivary gland tumors and Epstein-Barr virus (EBV) infection: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2017;18:1201-6.

  22. She Y, Nong X, Zhang M, Wang M. Epstein-Barr virus infection and oral squamous cell carcinoma risk: a meta-analysis. PLoS One. 2017;12(10):e0186860.

  23. Aromseree S, Pientong C, Sunthamala N, Swangphon P, Chaiwongkot A, Kongyingyoes B, Patarapadungkit N, Chumworathayee B, Ekalaksananan T. Co-infection of Epstein-Barr virus (EBV) with high risk human papillomavirus (HR-HPV) is a significant risk of cervical cancer. Int J Infect Dis. 2012;16:e69.

  24. Al-Thawadi H, Ghabreau L, Aboulkassim T, Yasmeen A, Vranic S, Batist G, Al Moustafa AE. Coincidence of Epstein-Barr virus and high-risk human papillomaviruses in cervical cancer of Syrian women. Front Oncol. 2018;8:250.

  25. McCormick TM, Canedo NH, Furtado YL, Silveira FA, de Lima RJ, Rosman AD, Almeida Filho GL, Carvalho MGC. Association between human papillomavirus and Epstein-Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study. Diagn Pathol. 2015;10:59-66.

  26. Lattario F, Furtado YL, Fonseca R, Silveira FA, do Val IC, Almeida G, Carvalho MGC. Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions. Int J Gynecol Cancer. 2008;18:785-9.

  27. Lattario F, Furtado YL, Silveira FA, do Val IC, Almeida G, da Costa Carvalho MG. Evaluation of DAPK gene methylation and HPV and EBV infection in cervical cells from patients with normal cytology and colposcopy. Arch Gynecol Obstet. 2008;277:505-9.

  28. Aromseree S, Pientong C, Swangphon P, Chaiwongkot A, Patarapadungkit N, Kleebkaow P, Tungsiriwattana T, Kongyingyoes B, Vendrig T, Middeldorp JM, Ekalaksananan T. Possible contributing role of Epstein-Barr virus (EBV) as a cofactor in human papillomavirus (HPV)-associated cervical carcinogenesis. J Clin Virol. 2015;73: 70-6.

  29. Xu M, Zhang WL, Zhu Q, Zhang S, Yao YY, Xiang T, Feng QS, Zhang Z, Peng RJ, Jia WH, He GP, Feng L, Zeng ZL, Luo B, Xu RH, Zeng MS, Zhao WL, Chen SJ, Zeng YX, Jiao Y. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics. 2019;9: 1115-24.

  30. Kahla S, Oueslati S, Achour M, Kochbati L, Chanoufi MB, Maalej M, Oueslati R. Correlation between EBV co-infection and HPV16 genome integrity in Tunisian cervical cancer patients. Braz J Microbiol. 2012;43:744-753.

  31. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56-61.

  32. Vranic S, Cyprian FS, Akhtar S, Al Moustafa AE. The role of Epstein-Barr virus in cervical cancer: a brief update. Front Oncol. 2018;8:113-20.

  33. Cohen JI. Epstein-Barr virus vaccines. Clin Transl Immunol. 2015;4:e32-7.

  34. Rajcani J, Banati F, Szenthe K, Szathmary S. The potential of currently unavailable herpes virus vaccines. Expert Rev Vaccines. 2018;17:239-48.

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain